Antibody Developability Analysis.
Gain deeper insights into the molecular characteristics that influence antibody developability.
What is an Antibody Developability Assessment?
Antibody developability assessments evaluate the molecular and physicochemical properties of an antibody to determine its suitability for therapeutic development. Characteristics such as post-translational modifications (PTMs), glycosylation patterns, disulfide bond connectivity, and binding properties can influence antibody stability, structural integrity, aggregation propensity, and serum half-life.
Identifying potential liabilities early helps guide candidate selection, inform optimization strategies, and reduce risks throughout therapeutic development.
Rapid Novor Antibody Developability Toolkit.
Antibody developability is multifaceted, and no single analytical technique can provide a complete assessment of a candidate.
Rapid Novor combines complementary analytical approaches to help researchers investigate different aspects of antibody structure, sequence, and function.
Antibody Developability Analysis with Mass Spectrometry & SPR

Liquid chromatography-mass spectrometry (LC-MS) provides highly sensitive, accurate, and detailed characterization of antibody composition, modifications, and key product attributes. By identifying PTMs, profiling glycan structures, and mapping disulfide bonds, MS helps uncover molecular features that may influence stability, structural integrity, and product quality.
Surface plasmon resonance (SPR) provides quantitative insights into antibody binding kinetics and affinity. FcRn binding analysis helps characterize interactions relevant to antibody recycling and serum half-life, while SPR-based stability assessments can reveal changes in binding properties following exposure to different stress conditions.
Together, these technologies provide a more comprehensive understanding of antibody characteristics to support informed candidate selection, characterization, and optimization.
Getting Started.
Requirements
Sample requirements vary depending on the type and number of analyses requested. As a general guideline, approximately 50 μg of antibody is required per LC-MS analysis and 100 μg per SPR analysis*.
*Sample requirements may vary.
Contact our scientists to discuss your project and determine the specific sample requirements for your analysis.
Timeline
Typical project timelines range from 2–4 weeks, depending on the type and number of analyses requested. Contact our scientists to discuss your project scope and receive an estimated timeline.
Talk to Our Scientists.
We Have Sequenced 10,000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics
Talk to our scientists. We have sequenced over 9000+ antibodies and we are eager to help you.
Antibody Sequencing, Discovery and Characterization Services.
Antibody Sequencing & Discovery Services.
REmAb® mAb Sequencing
Monoclonal antibody sequencing from small antibody samples, no need for hybridoma or DNA information. Full sequence in record time.
Explore Antibody Sequencing Services
REpAb® pAb Sequencing
Polyclonal antibody sequencing and antibody discovery service. Sequence antibodies from blood or a polyclonal mixture.
Explore Antibody Discovery Services
RapidSPR™ Analysis
Label-free evaluation of antibody-antigen binding using surface plasmon resonance on Biacore or Nicoya. Can be employed for detailed kinetic profiling, kinetics screening, or epitope binning.
Explore SPR Services
RapidHDX-MS™
Mass spec based epitope mapping. Epitope mapping for identify the binding site of an antibody to its corresponding antigen with the highest confidence and resolution.
Explore HDX-MS Epitope Mapping Service
MATCHmAb™
Antibody verification by rapid peptide mapping. Antibody sequence confirmation and full detailed mapping for development purposes.
Explore Peptide Mapping Service
Antibody Characterization
LC-MS analysis for study of antibody glycosylation, disulfide bonds, post-translational modifications, sequence variants, intact mass and size.
Explore Antibody Characterization Services